共 50 条
- [41] Vaniprevir plus peginterferon alfa-2a and ribavirin in treatment-experienced Japanese patients with hepatitis C virus genotype 1 infection: a randomized phase II studyJournal of Gastroenterology, 2015, 50 : 238 - 248Norio HayashiNiloufar MobasheryNamiki Izumi
- [42] Vaniprevir plus peginterferon alfa-2a and ribavirin in treatment-experienced Japanese patients with hepatitis C virus genotype 1 infection: a randomized phase II studyJOURNAL OF GASTROENTEROLOGY, 2015, 50 (02) : 238 - 248Hayashi, NorioMobashery, NiloufarIzumi, Namiki
- [43] CONTROLLED RELEASE NITAZOXANIDE IN COMBINATION WITH PEGINTERFERON ALFA-2A PLUS RIBAVIRIN RESULTS IN HIGH EARLY VIROLOGIC RESPONSE RATES FOR TREATMENT OF CHRONIC HEPATITIS C GENOTYPE 4HEPATOLOGY, 2009, 50 (04) : 1038A - 1038AKeeffe, Emmet B.Elfert, AsemAbousail, SabryRossignol, Jean-Francois
- [44] PEGINTERFERON ALFA-2A PLUS RIBAVIRIN COMBINATION TREATMENT IN CHRONIC HEPATITIS C POSTRENAL TRANSPLANT PATIENTS: AN INTERIM ANALYSISHEPATOLOGY, 2010, 52 (04) : 789A - 789ASanai, Faisal M.Mousa, Dujanah H.Aleid, HassanAlShoail, GhadaAlMdani, Abdullah S.Al-Ashgar, Hamad I.Almeshari, Khalid A.Bzeizi, Khalid I.
- [45] Daclatasvir combined with peginterferon alfa-2a and ribavirin in Japanese patients infected with hepatitis C genotype 1ANTIVIRAL THERAPY, 2014, 19 (05) : 501 - 510Izumi, NamikiYokosuka, OsamuKawada, NorifumiOsaki, YukioYamamoto, KazuhideSata, MichioIshikawa, HirokiUeki, TomokoHu, WenhuaMcPhee, FionaHughes, Eric A.Kumada, Hiromitsu
- [46] Peginterferon Lambda-1a/Ribavirin with Daclatasvir or Peginterferon Alfa-2a/Ribavirin with Telaprevir for Chronic Hepatitis C Genotype 1bJOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2016, 36 (11): : 635 - 643Flisiak, RobertKawazoe, SeijiZnoyko, OlgaAssy, NimerGadano, AdrianKao, Jia-HorngLee, Kwan-SikZwirtes, RicardoPortsmouth, SimonDong, YupingXu, DongKumada, HiromitsuSrinivasan, Subasree
- [47] High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practiceCLINICAL AND MOLECULAR HEPATOLOGY, 2013, 19 (01) : 60 - 69Heo, Nae-YunLim, Young-SukLee, Han ChuLee, Yung SangKim, Kang MoByun, Kwan SooHan, Kwang-HyubLee, Kwan SikPaik, Seung WoonYoon, Seung KewSuh, Dong Jin
- [48] Response to Pegylated Interferon Alfa-2a and Ribavirin in Chronic Hepatitis C Genotype 4JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (09) : 1576 - 1583El Makhzangy, HeshamEsmat, GamalSaid, MohamedElRaziky, MaissaShouman, SoheirRefai, RashaRekacewicz, ClaireGad, Rita RaafatVignier, NicolasAbdel-Hamid, MohamedZalata, KhaledBedossa, PierrePol, StanislasFontanet, ArnaudMohamed, Mostafa K.
- [49] Responses to peginterferon alfa-2a versus alfa-2b plus ribavirin in a Mexican population with chronic hepatitis CJOURNAL OF VIRAL HEPATITIS, 2013, 20 : 25 - 25Sandoval, J.Mata, J.Gaytan, J.
- [50] Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naive Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized TrialSCIENTIFIC REPORTS, 2015, 5Liu, Chen-HuaHuang, Chung-FengLiu, Chun-JenDai, Chia-YenHuang, Jee-FuLin, Jou-WeiLiang, Cheng-ChaoYang, Sheng-ShunLin, Chih-LinSu, Tung-HungYang, Hung-ChihChen, Pei-JerChen, Ding-ShinnChuang, Wan-LongKao, Jia-HorngYu, Ming-Lung